Higher prescription of antidepressants and/or anxiolytics among chronic obstructive pulmonary disease patients.
Charlotte E PelgrimJan Maurik van den HeuvelGert FolkertsJohan GarssenAnke H Maitland-van der ZeeAletta D KraneveldPublished in: Therapeutic advances in respiratory disease (2021)
The rates of chronic ATD and ANX use and the risk of having depression and/or anxiety are especially high in COPD patients, indicating that psychiatric problems are more common in COPD than in most other chronic diseases. In general, age and gender strongly influence the risk of chronically using ATDs and ANXs.The reviews of this paper are available via the supplemental material section.